Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to $239.7 million.

  • Adma Biologics' Shares Outstanding rose 138.86% to $239.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.7 million, marking a year-over-year increase of 138.86%. This contributed to the annual value of $236.6 million for FY2024, which is 467.02% up from last year.
  • Adma Biologics' Shares Outstanding amounted to $239.7 million in Q3 2025, which was up 138.86% from $239.4 million recorded in Q2 2025.
  • Adma Biologics' 5-year Shares Outstanding high stood at $239.7 million for Q3 2025, and its period low was $123.0 million during Q1 2021.
  • For the 5-year period, Adma Biologics' Shares Outstanding averaged around $208.1 million, with its median value being $224.5 million (2023).
  • Per our database at Business Quant, Adma Biologics' Shares Outstanding soared by 8666.2% in 2021 and then soared by 138.86% in 2025.
  • Over the past 5 years, Adma Biologics' Shares Outstanding (Quarter) stood at $195.8 million in 2021, then grew by 13.28% to $221.8 million in 2022, then grew by 1.91% to $226.1 million in 2023, then increased by 4.67% to $236.6 million in 2024, then grew by 1.28% to $239.7 million in 2025.
  • Its Shares Outstanding was $239.7 million in Q3 2025, compared to $239.4 million in Q2 2025 and $238.5 million in Q1 2025.